Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001183515 | SCV001349265 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001474519 | SCV001678690 | likely benign | Aortic aneurysm, familial thoracic 4 | 2023-02-26 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001183515 | SCV004824323 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-06-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001183515 | SCV005139115 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-05-07 | criteria provided, single submitter | clinical testing | The c.5614-5G>A intronic variant results from a G to A substitution 5 nucleotides upstream from coding exon 39 in the MYH11 gene. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Based on the available evidence, the clinical significance of this variant remains unclear. |